Work

Forodesine, a Purine Nucleoside Phosphorylase (PNP) Inhibitor, Shows Clinical Activity In a Phase 2 Trial In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL) – Interim Analysis

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1397.1397

Authors: Taimur Sher, Jose Azar, Stephen Spurgeon, John Catalano, Richard R. Furman, Miles Prince, Nancy L. Bartlett, Simon Durrant, Ralph Boccia, Aisha Masood, Scott Lyman, Jean Cantey-Kiser, William P Sheridan, Asher Chanan-Khan

Institutions: Roswell Park Comprehensive Cancer Center, Indiana University, OHSU Knight Cancer Institute, Frankston Hospital, Cornell University, Weill Cornell Medicine, Peter MacCallum Cancer Centre, Washington University in St. Louis, Royal Brisbane and Women's Hospital, Center for Cancers and Blood Disorders, BioCryst Pharmaceuticals (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979324668

FWCI:

Cites:

Cited by: 1

Related to: 10